{1}

##LOC[OK]## ##LOC[Cancel]##

{1}

##LOC[OK]## ##LOC[Cancel]##

PWSA USA Scientific Conference

Overview
Faculty/Disclosure to Learners
Schedule

Add to Calendar PWSA USA Scientific Conference 11/15/2017 8:00:00 AM 11/16/2017 5:00:00 PM America/New_York For More Details: https://wmed.cloud-cme.com/course/courseoverview?EID=7788 Description: PWSA USA Scientific ConferenceFor more information, contact James Loker, MD (269) 341-8786. Caribe Royale Orlando false MM/DD/YYYY

Overview

For more information, contact James Loker, MD (269) 341-8786.

Date & Location

Wednesday, November 15, 2017, 8:00 AM - Thursday, November 16, 2017, 5:00 PM, Caribe Royale Orlando

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Western Michigan University Homer Stryker M.D. School of Medicine and National PWSA. Western Michigan University Homer Stryker M.D. School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Western Michigan University Homer Stryker M.D. School of Medicine designates this live activity for a maximum of 12.0 AMA PRA Category 1 Creditsä. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credits

AMA PRA Category 1 Credits™ (10.00 hours), Other Learner Attendance (10.00 hours)

Keywords: LIVE AMA PRA Category 1 Credit™Attendance

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Jessica Bohonowych, PhD

Faculty

Nothing to disclose

Merlin Butler, MD

Faculty

Nothing to disclose

Kathy Clark, NP

Faculty

Nothing to disclose

Amparo de la Pena, PhD

Faculty

Dr. de la Pena is an employee and minor shareholder of Chorus (a division of Eli Lilly). Chorus is currently under contract with GLWL, INC for the development of GLWL-01

Timothy Dellenbaugh, MD

Faculty

Nothing to disclose

Dan Driscoll, MD, MD, PhD
University of Florida College of Medicine

Faculty

Nothing to disclose

Fred Fiedorek, MD

Faculty

Salary-Rhythm Pharmaceuticals, Inc.

Janice Forster, MD

Faculty

Fees for Non-CE Services Received Directly from a Commercial Interest or its Agent-ISIS Pharmaceuticals, Inc.|Consulting Fee-Latham Centers|Consulting Fee-Grant, Icahn School of Medicine at Mount Sinai, NY

June-Anne Gold, MBBS

Faculty

Nothing to disclose

Andrea M Haqq, MD

Faculty

Nothing to disclose

Tony Holland, MD

Faculty

Nothing to disclose

Frederick Kweh, PhD

Faculty

Nothing to disclose

James Loker, MD
Helen DeVos Childrens Hospital

Faculty

Nothing to disclose

Ranim Mahmoud, MD

Faculty

Nothing to disclose

Jackie Mallow

Faculty

Nothing to disclose

Ann M Manzardo, PhD, Associate Professor
University of Kansas Medical Center

Faculty

Consulting Fee-INSYS, Inc.|Consulting Fee-Alize

Jennifer Miller

Faculty

Grant/Reserch Support-Rhythm Pharmaceuticals

Parisa Salehi, MD

Faculty

Nothing to disclose

DEEPAN SINGH, MD
Maimonides Medical Center

Faculty

Nothing to disclose

Stefan Stamm, PhD

Faculty

Nothing to disclose

Theresa Strong, PhD

Faculty

Nothing to disclose

Harold van Bosse, MD

Faculty

Nothing to disclose

Krista Viau, PhD, RD, CSP

Faculty

Nothing to disclose

Nicolette Weisensel, MD

Faculty

Nothing to disclose

Wednesday, November 15, 2017

Utility of Pharmacogenomics in PWS

Janice Forster, MD

Utility of Pharmacogenomics in PWS
2:00PM - 3:00PM
Janice Forster, MD

Updated Consensus Statement for Growth Hormone Treatment

Jennifer Miller, MD, MS

No CME Available

Updated Consensus Statement for Growth Hormone Treatment
3:00PM - 4:00PM
Jennifer Miller

Role of the International Prader-Willi Syndrome Organization

Tony Holland, MD

Role of the International Prader-Willi Syndrome Organization
4:00PM - 4:30PM
Tony Holland, MD

Use of the Vagal Nerve Stimulator in PWS

Use of the Vagal Nerve Stimulator in PWS
4:30PM - 5:00PM
Tony Holland, MD

Updated Screening and Management Options for Hip Dysplasia and Scoliosis

Harold van Bosse, MD

Updated Screening and Management Options for Hip Dysplasia and Scoliosis
5:00PM - 5:30PM
Harold van Bosse, MD

Proposed Revision of the ICD-10 Code for PWS/Brain and Tissue Bank for PWS

Theresa Strong, PhD

Proposed Revision of the ICD-10 Code for PWS
5:30PM - 6:00PM
Theresa Strong, PhD

Thursday, November 16, 2017

An Overview of Prader-Willi Syndrome: Infancy through adulthood

Jennifer Miller

An Overview of Prader-Willi Syndrome: Infancy through Adulthood
8:00AM - 9:00AM
Jennifer Miller

Session I

NIH Rare Disease Consortium: Prader-Willi Syndrome and Early-onset Morbid Obesity- A Review of Natural History Study by Merlin G. Butler

Experience of the First Multidisciplinary Adult Prader-Willi Syndrome Clinic in the USA by June-Anne Gold

Bipolar Disorder, A Previously Unexplored Psychiatric Comorbidity in Patients with Prader Willi Syndrome- A Case Series by Deepan Singh

Session I
9:00AM - 10:00AM
Merlin Butler, MD
June-Anne Gold, MBBS
DEEPAN SINGH, MD

BREAK

BREAK
10:00AM - 10:20AM

Session II

SNORD116 Missing in Prader-Willi Syndrome Regulates Microexon Splicing and mRNA Stability of Immediate Early Genes by Stefan Stamm

Von Economo neurons (VENs) in the Prader-Willi syndrome (PWS) brain: Too much of a good thing? By Janice Forster

Adverse Effects of N-Acetyl Cysteine Treatment of Excoriation (Skin Picking) Disorder in Prader-Willi Syndrome (PWS): Everything is Not Always Rainbows and Butterflies by Nicolette E. Weisensel

Potential Benefit of GLWL-01 Plasma AG Lowering in Patients with Prader-Willi Syndrome by Amparo de la Peña (No CME Available)

Silent Aspiration in Infants with Prader-Willi Syndrome Identified by Videofluoroscopic Swallow Study by Parisa Salehi

Session II
10:20AM - 12:00PM
Janice Forster, MD
Stefan Stamm, PhD
Nicolette Weisensel, MD
Amparo de la Pena, PhD
Parisa Salehi, MD

LUNCH

LUNCH BREAK
12:00PM - 1:00PM

Pharmacogenetic Testing in Psychiatry: Current Perspectives and Future Possibilities

Timothy Dellenbaugh

Pharmacogenetic Testing in Psychiatry: Current Perspectives and Future Possibilities
1:00PM - 2:00PM
Timothy Dellenbaugh, MD

Session III

Analysis of Maternal and Fetal Outcomes in Patients with Prader-Willi Syndrome: Multicenter Study by R. Mahmoud

Hyperinsulinemia Promotes Early Weight Gain in Prader-Willi syndrome by Frederick A. Kweh

Catatonia and Neuroleptic Malignant Syndrome (NMS) in Prader-Willi Syndrome by Janice Forster

Session III
2:00PM - 3:00PM
Janice Forster, MD
Ranim Mahmoud, MD
Frederick Kweh, PhD

BREAK

BREAK
3:00PM - 3:20PM

Session IV

Exploring the Gut Microbiome as a Therapeutic Target in Children with PWS by Andrea Haqq

Effect of Diet Composition on Lean Body Mass and Metabolic Status in Children with Prader-Willi Syndrome: A Randomized Controlled Trial by Krista Viau

Results of a Phase 2 Study of the Melanocortin (MC)-4 Receptor (R) Agonist Setmelanotide (SET) in Prader-Willi Syndrome (PWS) by Fred T. Fiedorek

The Global Prader-Willi Syndrome Registry: Overview, Early Data, and Development by Jessica Bohonowych

Survival Trends in Prader-Willi Syndrome in Relationship to Cause of Death and Historical Time frame by Ann M. Manzardo

Session IV
3:20PM - 5:00PM
Ann M Manzardo, PhD, Associate Professor
Andrea M Haqq, MD
Krista Viau, PhD, RD, CSP
Fred Fiedorek, MD
Jessica Bohonowych, PhD